The radical new US hypertension guidelines, released 3 years after the previous scientific statement, have implications far beyond their intended recipients. They include a new definition for hypertension, lower treatment targets, and extended guidance on the implementation of multidisciplinary care, including self-monitoring of blood pressure. Some recommendations are likely to generate controversy.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Whelton, P. K. et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol. http://dx.doi.org/10.1016/j.jacc.2017.11.006 (2017).
Lim, S. S. et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2224–2260 (2012).
Ettehad, D. et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 387, 957–967 (2016).
Wright, J. T. Jr et al. A randomized trial of intensive versus standard blood-pressure control. N. Engl. J. Med. 373, 2103–2116 (2015).
D'Agostino, R. B. Sr et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117, 743–753 (2008).
Johnston, M. E. et al. Effects of labelling on income, work and social function among hypertensive employees. J. Chron. Dis. 37, 417–423 (1984).
Marshall, I. J., Wolfe, C. D. & McKevitt, C. Lay perspectives on hypertension and drug adherence: systematic review of qualitative research. BMJ 345, e3953 (2012).
Brunström, M. & Carlberg, B. Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels: a systematic review and meta-analysis. JAMA Intern. Med. http://dx.doi.org/10.1001/jamainternmed.2017.6015 (2017).
Arima, H. et al. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J. Hypertens. 24, 1201–1208 (2006).
Albarqouni, L., Doust, J. & Glasziou, P. Patient preferences for cardiovascular preventive medication: a systematic review. Heart 103, 1578–1586 (2017).
Acknowledgements
R.J.M. is funded by an NIHR Professorship (NIHR-RP-R2-12-015) and the NIHR Oxford CLAHRC.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
R.J.M. has received blood pressure monitoring equipment for research purposes from Lloyds Pharmacies and Omron. J.M. declares no competing interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
McManus, R., Mant, J. New US blood-pressure guidelines — who asked the patients?. Nat Rev Cardiol 15, 137–138 (2018). https://doi.org/10.1038/nrcardio.2017.222
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2017.222